The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Cardiovascular DiseaseDiabetes
Interventions
DIETARY_SUPPLEMENT

Flavonoid enrichment (cocoa / soy compounds)

Flavonoid compounds from cocoa (including epicatechin) and soy to be consumed for 365days in the experimental intervention (versus placebo consumption). 27g chocolate bar the vehicle for flavonoid enrichment.

DIETARY_SUPPLEMENT

Flavonoid enrichment (cocoa / soy compounds)

27g placebo chocolate bar to be consumed for 365 days.

Trial Locations (1)

NR47TJ

University of East Anglia (UK); School of Medicine, Health Policy and Practice, Norwich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Quadram Institute Bioscience

OTHER

collaborator

The Bertram Diabetes Centre & Radiology department (Norfolk & Norwich University Hospital, UK)

UNKNOWN

collaborator

Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

OTHER

collaborator

Diabetes UK

OTHER

collaborator

Frutarom Netherlands B.V. - Soy producer

UNKNOWN

collaborator

Barry Callebaut - chocolate manufacturer contracted to produce intervention foods

UNKNOWN

lead

University of East Anglia

OTHER

NCT00677599 - The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes | Biotech Hunter | Biotech Hunter